Related Experiment Video

Updated: Jul 13, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Increased platelet activity in patients with isolated coronary artery ectasia

Ayse Saatci Yasar1, Ali Riza Erbay, Selime Ayaz

  • 1Department of Cardiology, Turkiye Yuksek Ihtisas Hospital, Ankara, Turkey. drasaatciyasar@yahoo.com

Coronary Artery Disease
|August 19, 2007
PubMed

Insights

Patients with isolated coronary artery ectasia (CAE) show increased platelet activation, indicated by higher levels of P-selectin, beta-thromboglobulin (beta-TG), and platelet factor 4 (PF4) compared to healthy individuals.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hematology

Background:

  • Coronary artery ectasia (CAE) is often found with coronary artery disease, suggesting a possible link.
  • The mechanisms and clinical significance of CAE formation during atherosclerosis are not fully understood.
  • This study investigates platelet activation markers in isolated CAE patients.

Purpose of the Study:

  • To assess platelet activation in patients with isolated coronary artery ectasia (CAE).
  • To compare levels of specific platelet activation markers between isolated CAE patients and controls.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to measure plasma levels of P-selectin, beta-thromboglobulin (beta-TG), and platelet factor 4 (PF4).
  • The study included 32 patients with isolated CAE and 30 control participants with normal coronary arteries.
  • CAE was defined angiographically as a vessel diameter >= 1.5 times that of the adjacent normal segment.

Main Results:

  • Patients with isolated CAE exhibited significantly higher plasma levels of P-selectin, beta-TG, and PF4 compared to controls.
  • Specific mean levels were: P-selectin (248+/-46 vs. 154+/-32 ng/ml), beta-TG (51+/-19 vs. 21+/-9 ng/ml), and PF4 (58+/-23 vs. 33+/-11 ng/ml).
  • All comparisons showed statistically significant differences (P<0.001).

Conclusions:

  • This study provides the first evidence of elevated P-selectin, beta-TG, and PF4 in patients with isolated CAE.
  • These findings suggest increased platelet activation is associated with isolated coronary artery ectasia.
  • This highlights a potential role for platelet activity in the pathophysiology of CAE.
Abstract

More Related Videos

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...